D-496-2013 Class III Terminated
FDA drug recall D-496-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Mar 14, 2013 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing The recall status is terminated (terminated Jan 15, 2014). Affected quantity: 17,108 blister packs.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 5, 2013
- Initiation Date
- Mar 14, 2013
- Termination Date
- Jan 15, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,108 blister packs
Product description
Seasonale(R) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg, 3 extended-cycle tablet dispensers, 91 tablets each, Rx only, TEVA Women Health, Inc., Subsidiary of TEVA Pharmaceuticals USA, Inc., Sellersville, PA NDC 51285-058-66
Reason for recall
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing
Distribution pattern
Nationwide
Code information
NDC 51285-058-66 -- lot numbers 33802330A, exp 6/2013; and 33802464A, exp 6/2013.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-496-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026